Clinical Trial Update: A Study to Learn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC)

View source ↗

Summary

This clinical trial update describes a study evaluating brigatinib treatment information in Chinese participants with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alunbrig (Brigatinib)

Snippet

Sponsor: Takeda | Conditions: Non-small Cell Lung Cancer (NSCLC) | Status: ACTIVE_NOT_RECRUITING